-+ 0.00%
-+ 0.00%
-+ 0.00%

KYVERNA THERAPEUTICS - MIV-CEL DEMONSTRATES WELL-TOLERATED SAFETY PROFILE IN OVER 100 PATIENTS

Reuters·06/03/2026 12:00:03

Please log in to view news